This topic contains a solution. Click here to go to the answer

Author Question: A patient with a history of colorectal cancer underwent quantitative immunoassay of tumor antigen ... (Read 86 times)

gonzo233

  • Hero Member
  • *****
  • Posts: 557
A patient with a history of colorectal cancer underwent quantitative immunoassay of tumor antigen 242 to test for recurrence of colon cancer. Report code _____.
 a. 86294
  b. 86300
  c. 86316
  d. 86317

Question 2

Nick Miller had blood testing done to determine peroxidase activity, qualitative, feces. This was of a specimen obtained from a digital rectal exam (DRE). Report code _____.
 a. 82270
  b. 82271
  c. 82272
  d. 82274



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dyrone

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

c

Answer to Question 2

c




gonzo233

  • Member
  • Posts: 557
Reply 2 on: Jun 27, 2018
:D TYSM


Viet Thy

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Excellent

 

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

Did you know?

More than 20 million Americans cite use of marijuana within the past 30 days, according to the National Survey on Drug Use and Health (NSDUH). More than 8 million admit to using it almost every day.

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library